Text Size

25-hydroxyvitamin D and Fatigue: The VITALITY Study

This study is not yet open for participant recruitment.
Verified October 2012 by Ostfold Hospital Trust
Sponsor:
Collaborators:
Karolinska Institutet
Aarhus University Hospital
Oslo University Hospital
Alesund Hospital
Helse Stavanger HF
Sykehuset Telemark
Sykehuset Innlandet HF
Ostfold University College, Fredrikstad, Norway
Information provided by (Responsible Party):
Ostfold Hospital Trust
ClinicalTrials.gov Identifier:
NCT01718925
First received: October 29, 2012
Last updated: October 31, 2012
Last verified: October 2012
History of Changes
  Purpose

The burden of chronic disease is continuing to rise. Even though patients may be in remission or have quiescent disease, several studies have confirmed that symptoms, such as e.g., fatigue, is troublesome.

The primary aim of this study is to investigate whether or not there might be an association between levels of vitamin D and the subjective experience of fatigue in conditions, such as inflammatory bowel disease, diabetes mellitus, rheumatoid arthritis and irritable bowel syndrome.

Secondary aims is to study both the co-occurence and influence of pain, depression and anxiety.


Condition
Irritable Bowel Syndrome
Inflammatory Bowel Disease
Diabetes
Rheumatoid Arthritis

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Vitamin D, Fatigue and Patient Reported Outcome (PRO) in Chronic Somatic and Functional Disorders.

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Ostfold Hospital Trust:

Primary Outcome Measures:
  • Fatigue [ Time Frame: 2 years ] [ Designated as safety issue: No ]
    Fatigue and the impact of vitamin d levels


Estimated Enrollment: 1100
Study Start Date: October 2012
Estimated Study Completion Date: January 2015
Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts
Inflammatory Bowel Disease
Ulcerative Colitis and Crohns's disease patients will be recruited from sqeduled outpatient follow-up
Irritable Bowel Syndrome
Irritable Bowel patients will be recruited from sqeduled outpatient follow-up
Rheumatoid Arthritis
Rheumatoid Arthritis patients will be recruited from sqeduled outpatient follow-up
Diabetes Mellitus
Diabetes mellitus patients will be recruited from sqeduled outpatient follow-up

Detailed Description:

The burden of chronic disease is continuing to rise. Even though patients may be in remission or have quiescent disease, several studies have confirmed that symptoms, such as e.g., fatigue, is troublesome.Previous studies have confirmed that vitamin D deficiency is associated with both Crohn's disease and Rheumatoid Arthritis. Since Vitamin D is associated with both onset of chronic disease and energy, we aim in this study to assess its impact on fatigue in various chronic diseases.

The primary aim of this study is to investigate whether or not there might be an association between levels of vitamin D and the subjective experience of fatigue in conditions, such as inflammatory bowel disease, diabetes mellitus, rheumatoid arthritis and irritable bowel syndrome.

Secondary aims is to study both the co-occurence and influence of pain, depression and anxiety.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with an established diagnose of IBD, DIA, IBS or RA is eligible for inclusion in this study. Patients must be over 18 years of age. Disease activity will be measured using the SCCAI for ulcerative colitis, SCDAI for Crohn's disease, DAS-28 for rheumatoid arthritis. In Dia and IBD objective activity measures, such as calprotectin in stools and HbA1C, will be collected.

Criteria

Inclusion Criteria:

  • informed consent,
  • over 18 years of age

Exclusion Criteria:

  • dementia,
  • cognitive disorders,
  • not able to comply with the study procedures,
  • on active vitamin D treatment
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01718925

Contacts
Contact: Lars-Petter Jelsness-Jorgensen, Ph.D lars.p.jelsness-jorgensen@hiof.no

Sponsors and Collaborators
Ostfold Hospital Trust
Karolinska Institutet
Aarhus University Hospital
Oslo University Hospital
Alesund Hospital
Helse Stavanger HF
Sykehuset Telemark
Sykehuset Innlandet HF
Ostfold University College, Fredrikstad, Norway
Investigators
Principal Investigator: Lars-Petter Jelsness-Jørgensen, PhD Ostfold Hospital Trust
  More Information

No publications provided

Responsible Party: Ostfold Hospital Trust
ClinicalTrials.gov Identifier: NCT01718925     History of Changes
Other Study ID Numbers: 3256
Study First Received: October 29, 2012
Last Updated: October 31, 2012
Health Authority: Norway:National Committee for Medical and Health Research Ethics

Additional relevant MeSH terms:
Arthritis
Arthritis, Rheumatoid
Inflammatory Bowel Diseases
Intestinal Diseases
Irritable Bowel Syndrome
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
 Connective Tissue Diseases
Autoimmune Diseases
Immune System Diseases
Gastroenteritis
Gastrointestinal Diseases
Digestive System Diseases
Colonic Diseases, Functional
Colonic Diseases

ClinicalTrials.gov processed this record on May 21, 2013